BEIJING TIANTAN BIOLOGICAL PRODUCTS CO., LTD.

Other languages Beijing Tiantan Biological Products Co., Ltd.

Equities

600161

CNE000000WF9

End-of-day quote Shanghai S.E. Other stock markets 06:00:00 2024-05-23 pm EDT			5-day change	1st Jan Change
28.5 ^CNY	+0.07%		-2.73%	-7.89%

May. 16	Bank of China Executive Vice President Steps Down	MT
May. 02	ICBC, CCB Name Deputy Party Secretaries	MT

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Bank of China Executive Vice President Steps Down	May. 16
ICBC, CCB Name Deputy Party Secretaries	May. 01
Tiantan Biological Products' Q1 Profit Jumps 21%; Shares Rise 7%	Apr. 12
Beijing Tiantan Biological Products Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	Apr. 11
Tiantan Biological Products Scraps Clinical Trial of Intravenous Cytomegalovirus Human Immunoglobulin	Feb. 01
Beijing Tiantan Biological Products Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	Jan. 10
China Baoli Technologies Chairman Redesignated as Vice Chairman	Nov. 29
Didi Global Reports Q3 Revenue of RMB 51.4 Billion, Up 25% YoY	Nov. 13
DIDI- ON NOV 11, YI ZHANG RESIGNED AS DIRECTOR OF THE CO, CHEN S…	Nov. 13
Tiantan Biological Products Secures Another Blood Collection License	Nov. 02
Beijing Tiantan Biological Products Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023	23-10-25
Tiantan Biological Products' Profit Jumps 47.7% in First Three Quarters; Shares Up 5%	23-10-13
Tiantan Biological Products' Unit Gets Nod to Register Intravenous Human Immunoglobulin, Passes Regulatory Inspection	23-09-27
Beijing Tiantan Biological Products Lands Blood Collection License in China’s Liping County	23-09-15
Tiantan Biological Unit Registers Blood Disorder Treatment; Shares Jump 4%	23-09-11
Tiantan Biological Products Secures Another Blood Plasma Collection License	23-09-07
Beijing Tiantan Biological Products Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023	23-07-13
Tiantan Biological Products Gets License for Four Plasma Stations	23-06-27
Guangxi Wuzhou Communications' Vice Chairman Resigns	23-04-21
Beijing Tiantan Biological Products Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-04-12

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages Beijing Tiantan Biological Products Co., Ltd.

Equities

600161

CNE000000WF9

Other languages

Filters